EPS Bio Technology Corp.(TW:4183)
NT$14.500.00 (0.00%)
TW:4183
EPS Bio Technology Corp. financials statements
NT$14.50
At close:0.00 (0.00%)
EPS Bio Technology Corp. (4183) Ratios
EPS Bio Technology Corp. Ratios
TW:4183's free cash flow for Q2 2026 was NT$39.46M. For the 2026 fiscal year, TW:4183's free cash flow was decreased by NT$-1.61M and operating cash flow was NT$41.07M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.30 | 2.83 | 2.93 | 3.37 | 2.50 |
| Quick Ratio | 1.83 | 2.21 | 2.35 | 2.53 | 1.98 |
| Cash Ratio | 0.80 | 0.99 | 1.56 | 1.73 | 1.29 |
| Solvency Ratio | 0.03 | 0.13 | 0.15 | 0.19 | 0.13 |
| Operating Cash Flow Ratio | 0.00 | -0.25 | 0.44 | 0.05 | 0.20 |
| Short-Term Operating Cash Flow Coverage | 0.01 | -12.49 | 21.65 | 1.98 | 12.66 |
| Net Current Asset Value | NT$ 103.33M | NT$ 130.66M | NT$ 129.21M | NT$ 128.37M | NT$ 114.92M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.26 | 0.20 | 0.21 | 0.23 | 0.22 |
| Debt-to-Equity Ratio | 0.50 | 0.36 | 0.38 | 0.39 | 0.42 |
| Debt-to-Capital Ratio | 0.33 | 0.27 | 0.27 | 0.28 | 0.30 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 |
| Financial Leverage Ratio | 1.90 | 1.78 | 1.77 | 1.71 | 1.93 |
| Debt Service Coverage Ratio | 0.18 | 7.31 | 8.25 | 10.18 | 8.60 |
| Interest Coverage Ratio | -4.80 | 1.71 | 11.67 | 15.09 | 12.32 |
| Debt to Market Cap | 0.13 | 0.02 | 0.02 | 0.04 | 0.05 |
| Interest Debt Per Share | 5.99 | 4.70 | 4.95 | 5.19 | 5.41 |
| Net Debt to EBITDA | 2.81 | -0.55 | -1.80 | -1.16 | -1.69 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.40% | 21.34% | 24.61% | 23.18% | 25.12% |
| EBIT Margin | -1.82% | 4.40% | 6.08% | 6.38% | 5.35% |
| EBITDA Margin | 1.26% | 7.64% | 9.38% | 10.68% | 9.47% |
| Operating Profit Margin | -1.82% | 0.78% | 5.30% | 6.95% | 5.60% |
| Pretax Profit Margin | -1.93% | 3.95% | 5.63% | 5.92% | 4.90% |
| Net Profit Margin | -1.57% | 3.84% | 4.46% | 5.47% | 3.88% |
| Continuous Operations Profit Margin | -1.57% | 3.84% | 4.46% | 5.47% | 3.88% |
| Net Income Per EBT | 81.35% | 97.20% | 79.33% | 92.36% | 79.24% |
| EBT Per EBIT | 106.29% | 507.44% | 106.18% | 85.28% | 87.42% |
| Return on Assets (ROA) | -1.48% | 3.19% | 3.86% | 4.81% | 3.23% |
| Return on Equity (ROE) | -2.80% | 5.68% | 6.86% | 8.22% | 6.23% |
| Return on Capital Employed (ROCE) | -2.40% | 0.85% | 5.96% | 7.59% | 6.40% |
| Return on Invested Capital (ROIC) | -1.74% | 0.82% | 4.66% | 6.92% | 5.01% |
| Return on Tangible Assets | -1.48% | 3.20% | 3.88% | 4.84% | 3.26% |
| Earnings Yield | -1.99% | 3.13% | 3.33% | 5.76% | 4.26% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.20 | 2.94 | 4.95 | 5.72 | 4.62 |
| Payables Turnover | 5.74 | 4.40 | 4.76 | 6.11 | 4.42 |
| Inventory Turnover | 5.70 | 4.38 | 4.88 | 4.12 | 4.41 |
| Fixed Asset Turnover | 2.89 | 2.69 | 2.88 | 2.69 | 2.77 |
| Asset Turnover | 0.94 | 0.83 | 0.87 | 0.88 | 0.83 |
| Working Capital Turnover Ratio | 2.28 | 1.88 | 1.94 | 1.93 | 2.00 |
| Cash Conversion Cycle | 114.64 | 124.69 | 71.86 | 92.70 | 79.22 |
| Days of Sales Outstanding | 114.19 | 124.25 | 73.79 | 63.85 | 79.04 |
| Days of Inventory Outstanding | 63.99 | 83.39 | 74.83 | 88.62 | 82.78 |
| Days of Payables Outstanding | 63.55 | 82.95 | 76.76 | 59.77 | 82.60 |
| Operating Cycle | 178.18 | 207.64 | 148.62 | 152.48 | 161.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.03 | -1.36 | 2.31 | 0.21 | 1.35 |
| Free Cash Flow Per Share | -0.91 | -1.96 | 1.92 | -0.42 | 0.84 |
| Dividend Paid and CapEx Coverage Ratio | 0.02 | -0.97 | 1.68 | 0.16 | 0.79 |
| Capital Expenditure Coverage Ratio | 0.03 | -2.24 | 5.82 | 0.33 | 2.64 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.29 | 0.48 | 0.04 | 0.25 |
| Operating Cash Flow to Sales Ratio | 0.00 | -0.07 | 0.12 | 0.01 | 0.07 |
| Free Cash Flow Yield | -5.51% | -8.45% | 7.24% | -2.26% | 4.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -50.30 | 31.78 | 30.06 | 17.29 | 23.59 |
| Price-to-Sales (P/S) Ratio | 0.79 | 1.23 | 1.34 | 0.95 | 0.91 |
| Price-to-Book (P/B) Ratio | 1.41 | 1.82 | 2.06 | 1.43 | 1.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -18.16 | -11.84 | 13.81 | -44.23 | 21.96 |
| Price-to-Operating Cash Flow Ratio | 655.19 | -17.12 | 11.43 | 88.10 | 13.65 |
| Price-to-Earnings Growth (PEG) Ratio | 0.35 | -1.86 | -1.69 | 0.47 | -0.57 |
| Enterprise Value Multiple | 65.65 | 15.52 | 12.51 | 7.74 | 7.94 |
| Enterprise Value | 412.75M | 534.73M | 551.39M | 383.05M | 360.97M |
| EV to EBITDA | 65.65 | 15.52 | 12.51 | 7.74 | 7.94 |
| EV to Sales | 0.83 | 1.19 | 1.17 | 0.83 | 0.75 |
| EV to Free Cash Flow | -18.97 | -11.44 | 12.07 | -38.48 | 18.10 |
| EV to Operating Cash Flow | 684.50 | -16.54 | 9.99 | 76.64 | 11.25 |
| Tangible Book Value Per Share | 11.69 | 12.69 | 12.75 | 12.80 | 12.35 |
| Shareholders’ Equity Per Share | 11.81 | 12.76 | 12.83 | 12.96 | 12.57 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.03 | 0.21 | 0.08 | 0.21 |
| Revenue Per Share | 21.00 | 18.91 | 19.71 | 19.47 | 20.18 |
| Net Income Per Share | -0.33 | 0.73 | 0.88 | 1.07 | 0.78 |
| Tax Burden | 0.81 | 0.97 | 0.79 | 0.92 | 0.79 |
| Interest Burden | 1.06 | 0.90 | 0.93 | 0.93 | 0.92 |
| Research & Development to Revenue | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| SG&A to Revenue | 0.12 | 0.13 | 0.12 | 0.12 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.08 | -1.87 | 2.09 | 0.18 | 1.36 |
Currency in TWD
